These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 26769827)

  • 1. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
    Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
    J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multiple faces of tryptophan in bone biology.
    Al Saedi A; Sharma S; Summers MA; Nurgali K; Duque G
    Exp Gerontol; 2020 Jan; 129():110778. PubMed ID: 31705966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
    Nayak BN; Buttar HS
    J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
    Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
    Int Urol Nephrol; 2001; 33(2):399-404. PubMed ID: 12092667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An expanding range of targets for kynurenine metabolites of tryptophan.
    Stone TW; Stoy N; Darlington LG
    Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
    Forrest CM; Mackay GM; Oxford L; Stoy N; Stone TW; Darlington LG
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1078-87. PubMed ID: 17042918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis.
    Vidal C; Li W; Santner-Nanan B; Lim CK; Guillemin GJ; Ball HJ; Hunt NH; Nanan R; Duque G
    Stem Cells; 2015 Jan; 33(1):111-21. PubMed ID: 25186311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures.
    Muñóz-Hoyos A; Molina-Carballo A; Rodríguez-Cabezas T; Uberos-Fernández J; Ruiz-Cosano C; Acuña-Castroviejo D
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):667-77. PubMed ID: 9497873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan metabolites and brain disorders.
    Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
    Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
    Shilov IuE; Bezrukov MV
    Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central kynurenine pathway shift with age in women.
    de Bie J; Guest J; Guillemin GJ; Grant R
    J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analgesic effects of tryptophan and its metabolites in the rat.
    Heyliger SO; Goodman CB; Ngong JM; Soliman KF
    Pharmacol Res; 1998 Oct; 38(4):243-50. PubMed ID: 9774487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study.
    Colle R; Masson P; Verstuyft C; Fève B; Werner E; Boursier-Neyret C; Walther B; David DJ; Boniface B; Falissard B; Chanson P; Corruble E; Becquemont L
    Psychiatry Clin Neurosci; 2020 Feb; 74(2):112-117. PubMed ID: 31599111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
    Badawy AA
    Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401.
    Mor A; Pawlak K; Kalaska B; Domaniewski T; Sieklucka B; Zieminska M; Cylwik B; Pawlak D
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.
    Bortolotti P; Hennart B; Thieffry C; Jausions G; Faure E; Grandjean T; Thepaut M; Dessein R; Allorge D; Guery BP; Faure K; Kipnis E; Toussaint B; Le Gouellec A
    BMC Microbiol; 2016 Jul; 16(1):137. PubMed ID: 27392067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.